March 27, 2025

PPARG Shows Promise for Diabetic Retinopathy

The protective effect of PPARG on background diabetic retinopathy and proliferative diabetic retinopathy was largely mediated by glucose control.

Conexiant

March 27, 2025

Study Finds Significant Increases in Prevalence, Severity of Astigmatism

Prolonged digital device use and reduced outdoor exposure following the COVID-19 pandemic may have contributed to the refractive changes.

Conexiant

March 27, 2025

Bausch & Lomb Recalls Some IOLs

"As much as we believe in the enVista platform, patient safety will always be our number one priority."

Conexiant

March 21, 2025

Preserflo MicroShunt Yields Positive Results for Normal Pressure Glaucoma

92.5% of eyes were medication-free at 12 months, compared with 0% preoperatively.

Conexiant

March 18, 2025

Parafoveal Area of the Retina: A Biomarker for Systemic Diseases

Retinal thinning was linked to MS, type 2 diabetes, hypertension, and hyperlipidemia, among others.

Conexiant

March 18, 2025

FDA Approves Expanded Label for ILUVIEN

The fluocinolone acetonide intravitreal implant is now indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, as well as DME.

Conexiant

March 14, 2025

Study Demonstrates Outcomes of CNV Removal for hESC-RPE

“Safe CNV removal is a prerequisite for successful hESC-RPE transplantation in patients with wet AMD,” researchers found.

Conexiant

March 14, 2025

Higher Alcohol Consumption Associated with Higher Odds of Glaucoma

Women who consumed four or more drinks per week had a 52% increased risk of POAG.

Conexiant

March 14, 2025

Optometrist and Optician Defend Their Practice From Looters

San Ramon local news reported that luxury-brand frames were targeted.

Conexiant